Table 1 Characteristics of the patient population, of the ECMO, and outcome data
From: Heparin-like effect in postcardiotomy extracorporeal membrane oxygenation patients
Variable | Overall (n = 41) | HLE (n = 23) | No HLE (n = 18) | P-value |
|---|---|---|---|---|
Pediatric patients (<16 years), number (%) | 22 (53.7) | 12 (52.2) | 10 (55.6) | 0.829 |
Veno-venous ECMO, number (%) | 8 (19.5) | 5 (21.7) | 3 (16.7) | 0.684 |
Veno-arterial ECMO, number (%) | 33 (80.5) | 18 (78.3) | 15 (83.3) | |
Phosphorylcholine coating, number (%) | 29 (70.7) | 15 (65.2) | 14 (77.8) | 0.380 |
Heparin coating, number (%) | 12 (29.3) | 9 (34.8) | 4 (22.2) | |
Days on ECMO, median (range) | 6 (1 to 12) | 7 (3 to 12) | 4 (1 to 12) | 0.008 |
Bleeding on ECMO (mL/kg/day), mean (SD) | 17 (13) | 15.5 (14) | 20.6 (11) | 0.144 |
Peak serum bilirubin on ECMO, mg/dL, mean (SD) | 4.4 (5.7) | 3.7 (3.2) | 5.3 (7.6) | 0.410 |
Sepsis, number (%) | 8 (19.5) | 7 (30.4) | 1 (5.6) | 0.046 |
Survived to hospital discharge, number (%) | 19 (46.3) | 9 (39.1) | 10 (55.6) | 0.295 |